Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

2022 Minority Graduate Student Abstract Achievement Award

November 18, 2022

The Minority Graduate Student Abstract Achievement Award is part of the ASH Abstract Achievement Award program. This award program is meant to encourage minority graduate students in the field of hematology and is part of the broader minority recruitment initiative at ASH, which also includes the Minority Medical Student Award Program (MMSAP), the Minority Resident Hematology Award Program (MRHAP), and the ASH-Harold Amos Medical Faculty Development Program (ASH-AMFDP) in partnership with the Robert Wood Johnson Foundation. The goal of the Minority Graduate Student Abstract Achievement Award is to attract and retain minority PhD students to the field of hematology through the ASH annual meeting. At this meeting, students will have the opportunity to hear the latest advances in hematology-related research and interact with ASH leadership, senior researchers, and minority physicians, scientists, and students. These awards go to select graduate students to acknowledge their accomplishments in the field of hematology.

Luis Correa, BA
University of Michigan
Abstract 2424: Sel1L, an Endoplasmic Reticulum Associated Degradation Adaptor, Regulates CD8+ Tcell Fate (203. Lymphocytes and Acquired or Congenital Immunodeficiency Disorders: Poster II)
Sunday, December 11, 2022: 6:00 PM-8:00 PM, Ernest N. Morial Convention Center, Hall D

Giovanni Botten
The University of Texas Southwestern Medical Center at Dallas
Abstract 419: Structural Variation Cooperates with Permissive Chromatin to Control Enhancer Hijacking-Mediated Oncogenic Transcription (603. Lymphoid Oncogenesis: Basic: Mechanisms in Leukemogenesis)
Sunday, December 11, 2022: 10:30 AM, Ernest N. Morial Convention Center, Room 393-396

Carlos Munoz, MS
The Regents of the University of California, San Diego
Abstract 2372: Apohemoglobin-Haptoglobin Complex Prevents Microvascular Dysfunction in Sickle Cell Mice: Potential Therapeutic Approach for Vaso-Occlusive Crisis (113. Hemoglobinopathies, Excluding Thalassemia: Basic and Translational: Poster II)
Sunday, December 11, 2022, 6:00 PM-8:00 PM, Ernest N. Morial Convention Center, Hall D

Claudia Cabrera, BS
Washington University in Saint Louis
Abstract 3072: Nonsense-Mediated RNA Decay Disruption Induces Altered Splicing in Spliceosome Mutant Cells (636. Myelodysplastic Syndromes—Basic and Translational: Poster II)
Sunday, December 11, 2022: 6:00 PM-8:00 PM, Ernest N. Morial Convention Center, Hall D

Kemi Akinnola, BS, MS
Albert Einstein College of Medicine
Abstract 3879: Periosteal Skeletal Stem Cells Can Migrate into the Bone Marrow and Support Hematopoietic Regeneration (506. Bone Marrow Microenvironment: Poster III)
Monday, December 12, 2022, 6:00 PM-8:00 PM, Ernest N. Morial Convention Center, Hall D

Ariel Blakey, MA, BA
Boston University
Abstract 3526: Disease Management Decision-Making Amongst Caregivers of Children with Sickle Cell Anemia (901. Health Services and Quality—Non-Malignant Conditions: Poster II)
Sunday, December 11, 2022, 6:00 PM-8:00 PM, Ernest N. Morial Convention Center, Hall D

Rolando Vedia, MS
The University of Texas Health Science Center At Houston
Abstract 1984: A Novel Approach to Reduce Toxicity and Preserve Efficacy of Chimeric Antigen Receptor T Cells for Adoptive Transfer (703. Cellular Immunotherapies: Basic and Translational: Poster I)
Saturday, December 10, 2022, 5:30 PM-7:30 PM, Ernest N. Morial Convention Center, Hall D

Nicole Arellano, BS
The University of Chicago
Abstract 451: Type 2 but Not Type 1 Calreticulin Mutants Exhibit Loss of Chaperone Function Due to C-Terminal Structural Interference, and Bind to Wild Type Calreticulin in a Dominant Negative Manner (631. Myeloproliferative Syndromes and Chronic Myeloid Leukemia: Basic and Translational: Molecular Consequences of MPN Driver and Co-mutations)
Sunday, December 11, 2022: 9:30 AM, Ernest N. Morial Convention Center, Room 275-277

Richard Marrero, PharmD
University of Florida
Abstract 2800: Genome-Wide Association Study Identifies Variants Associated with Clinical Outcomes in Pediatric Patients with Newly Diagnosed Acute Myeloid Leukemia (617. Acute Myeloid Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Poster II)
Sunday, December 11, 2022, 6:00 PM-8:00 PM, Ernest N. Morial Convention Center, Hall D

Sergio Barajas, BS
Indiana University School of Medicine
Abstract 2540: Chronic Inflammation Drives p53 Mutant Clonal Hematopoiesis Via Activating the NLRP1 Inflammasome (503. Clonal Hematopoiesis, Aging and Inflammation: Poster II)
Sunday, December 11, 2022, 6:00 PM-8:00 PM, Ernest N. Morial Convention Center, Hall D

Ginette Balbin-Cuesta, MD, PhD
University of Michigan
Abstract 3650: Identifying Novel Regulators of Erythroid Maturation and Proliferation Using a Genome-Scale CRISPR Activation Screen (101. Red Cells and Erythropoiesis, Excluding Iron: Poster III)
Monday, December 12, 2022, 6:00 PM-8:00 PM, Ernest N. Morial Convention Center, Hall D

Caroline Kuczynski, BS
Wake Forest School of Medicine
Abstract 3673: Novel Sheep Model of Sickle Cell Disease Reproduces Human Clinical and Laboratory Parameters (113. Hemoglobinopathies, Excluding Thalassemia: Basic and Translational: Poster III)
Monday, December 12, 2022, 6:00 PM-8:00 PM, Ernest N. Morial Convention Center, Hall D

 

Close Modal

or Create an Account

Close Modal
Close Modal